# Trade Mark Journal No.2026/030 24 July 2026

## WO0000001926639 (42,44)

Office of origin: United States of America

Date of International Registration:14 May 2026
Date of designation in the UK: 14 May 2026

International priority date claimed: 19 November 2025 (United States of America) (99505734)

Class 42
  Providing medical and scientific research information; providing medical research and scientific research information in the field of oncology via the internet; medical and scientific research information in the field of pharmaceuticals and oncology; providing information about medical research via a website; providing information about medical research in the field of pharmaceuticals and oncology.
Class 44
  Providing medical information; providing medical information in the field of oncology; providing medical information via a website; providing medical information from a web site; providing medical information in the field of treatment for cancer.

Zentalis Pharmaceuticals, Inc.

Representative: Christopher K. Albert Hamilton, Brook, Smith & Reynolds, P.C., 155 Seaport Boulevard, Boston MA 02210, UNITED STATES OF AMERICA